CN104013745A - Traditional Chinese medicine preparation for treating hepatitis B - Google Patents
Traditional Chinese medicine preparation for treating hepatitis B Download PDFInfo
- Publication number
- CN104013745A CN104013745A CN201310063985.8A CN201310063985A CN104013745A CN 104013745 A CN104013745 A CN 104013745A CN 201310063985 A CN201310063985 A CN 201310063985A CN 104013745 A CN104013745 A CN 104013745A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- hepatitis
- medicine preparation
- traditional chinese
- treating hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine preparation for treating hepatitis B. The traditional Chinese medicine preparation is prepared from the following traditional Chinese medicine raw materials by weight: 4-15g of szechwan Chinaberry fruits, 20-40g of oriental wormwood, 8-18g of jasmines, 10-20g of salviae miltiorrhizae, 6-14g of poria cocos, 6-14g of rhizoma alismatis and 4-15g of radix pseudostellariae. The preparation disclosed by the invention is reasonable in formula, convenient to take and free from toxic and side effects, and can be used for effectively treating hepatitis B and alleviating the pain of patients.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of hepatitis B, belong to the field of Chinese medicines.
Background technology
Hepatitis B, is called for short hepatitis B, is a kind of by caused disease after hepatitis B virus (HBV) infection body.Hepatitis B virus is a kind of Hepadna Virus, is mainly present in hepatocyte and damages hepatocyte, causes hepatocyte inflammation, necrosis, fibrosis.Hepatitis B is divided acute and chronic two kinds.Acute hepatitis B 90% can spontaneous recovery in adult, and chronic hepatitis B performance differs, and is divided into HBV chronic carrier, chronic active hepatitis B, hbv-liver cirrhosis etc.The current hepatitis B virus carrying rate of China is 7.18%, and wherein approximately 1/3rd have hepatic injury repeatedly, shows as hepatitis B or the liver cirrhosis of activeness.
Summary of the invention
The object of the invention is to provide a kind of Chinese medicine preparation that can treat hepatitis B, and this Chinese medicine preparation be take natural Chinese medicines as raw material, evident in efficacy and have no side effect.
The solution of the present invention is as follows: a kind of Chinese medicine preparation for the treatment of hepatitis B, by the raw material of Chinese medicine of following weight, made: Fructus Toosendan 4-15g, Herba Artemisiae Scopariae 20-40g, Fructus Gardeniae 8-18g, Radix Salviae Miltiorrhizae 10-20g, Poria 6-14g, Rhizoma Alismatis 6-14g, Radix Pseudostellariae 4-15g.
Treat a Chinese medicine preparation for hepatitis B, its preferred version is made by the raw material of Chinese medicine of following weight: Fructus Toosendan 6-12g, Herba Artemisiae Scopariae 25-35g, Fructus Gardeniae 10-14g, Radix Salviae Miltiorrhizae 12-18g, Poria 8-12g, Rhizoma Alismatis 8-12g, Radix Pseudostellariae 6-12g.
Treat a Chinese medicine preparation for hepatitis B, its preferred plan is made by the raw material of Chinese medicine of following weight: Fructus Toosendan 9g, Herba Artemisiae Scopariae 30g, Fructus Gardeniae 12g, Radix Salviae Miltiorrhizae 15g, Poria 10g, Rhizoma Alismatis 10g, Radix Pseudostellariae 9g.
Each taste herbal pharmacology effect:
Fructus Toosendan: nature and flavor are cold in nature, bitter in the mouth; Slightly poisonous.Function cures mainly: soothing liver-QI promoting the circulation of QI to relieve pain, anthelmintic.For the breast side of body, abdominal distention, colic, abdominal pain due to worm stagnation.
Herba Artemisiae Scopariae: bitter, pungent, be slightly cold.Return spleen, stomach, liver, gallbladder meridian.Function cures mainly: clearing away damp-heat, jaundice eliminating subcutaneous ulcer.For jaundice oliguria, eczema pruritus, infectious jaundice type hepatitis.
Fructus Gardeniae: hardship, cold.Enter the heart, liver, lung, stomach warp.Cure mainly: control calentura restlessness of asrhenia type and insomnia, jaundice, gonorrhea, quenches one's thirst, conjunctival congestion, pharyngalgia, spits blood, epistaxis, dysentery, hematuria, pathopyretic ulcer, sprains and swells and ache.
Radix Salviae Miltiorrhizae: hardship, is slightly cold.Enter the heart, Liver Channel.Effect: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.Cure mainly: menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia; Hepatosplenomegaly, angina pectoris.
Poria: sweet, light, flat.GUIXIN warp, lung meridian, spleen channel, kidney channel.Diuretic medicine; Diuretics with the action of eliminating dampness.Cure mainly: dysuria; Edema distension; Phlegm retention cough with dyspnea; Vomiting; Insufficiency of the spleen lack of appetite; Have loose bowels; Palpitation and restlessness; Insomnia forgetfulness; Seminal emission nebulousurine.
Rhizoma Alismatis: sweet in the mouth; Light; Cold in nature.Return kidney; Urinary bladder channel.Function cures mainly: promoting diuresis to eliminate damp pathogen; Expel the heat-evil treating stranguria.Main dysuria; The puckery pain of pyretic stranguria; Edema distension; Have loose bowels; Dizziness due to fluid-retention; Seminal emission.
Radix Pseudostellariae: sweet, micro-hardship, tepor.Enter the heart, spleen, lung three warps.Qi-restoratives medicine, Qi-tonifying drug.Effect: mend strengthening spleen and lung, supplementing QI for promoting the production of body fluid.Control cough due to deficiency of the lung, insufficiency of the spleen lack of appetite, cardiopalmus, palpitation with a distress feeling, edema, quenches one's thirst, and spirit is tired.
The present invention implements by following measure: adopt slow fire to decoct with water required raw material of Chinese medicine, and concentrated after filtering, pack in bottle, every bottle of 250ml adds the Mel of 10ml in addition in every bottle, encapsulates standby.
Usage and dosage of the present invention: patient's morning and evening service once every day, each serving 125ml.
Beneficial effect of the present invention is: reasonable recipe, taking convenience, has no side effect, and can effectively treat hepatitis B, solves patient suffering.
Below in conjunction with clinical testing data, beneficial effect of the present invention is described:
1,, from August, 2010 to 2012 year December, the inventor applies the made Chinese medicine preparation of the present invention and observes geolotolepsy patient after treatment 100 routine apoplexy.Male 44 people wherein, women 59 people; The oldest person 62 years old, age reckling 22 years old, 41 years old mean age.
2, diagnostic criteria:
Slight: the state of an illness is lighter, can repeatedly occur weak, dizzy, appetite goes down to some extent, detest oil, yellowish urine, uncomfortable liver area, sleep is not good enough, liver touches slightly greatly pain, can have slight splenomegaly.Some cases symptom, sign lack as.Liver function index is 1 or 2 mile abnormality only.
Moderate: symptom, sign, lab testing occupy between slight and severe.
Severe: have obvious or lasting hepatitis symptom, as weak, poor appetite, abdominal distention, yellowish urine, loose stool etc., companion's hepatic facies, liver palm, spider angioma, splenomegaly, repeatedly or continue to raise, albumin reduces, gamma globulin obviously raises for ALT and (or) aspartate aminotransferase (AST).
4, criterion of therapeutical effect:
Cure: after treatment in 3-6 month, each symptom and clinical sign disappear, other objective determination index normals;
Effective: after treatment in 3-6 month, each symptom and clinical sign alleviate, and other objective determination indexs are obviously improved;
Invalid: after treatment in 3-6 month, each symptom and clinical sign are without improving or increasing the weight of, and other objective determination indexs are improved or increased the weight of.
5, therapeutic outcome: 100 routine hepatitis B patients are treated to observation, and 91 routine patients obtain curative effect, the effective effect of 7 routine string person, 2 routine patient treatments are invalid; Total cure rate 91%, total obvious effective rate 98%, total inefficiency 2%.
The specific embodiment
In order better to understand and to implement the present invention, below in conjunction with specific embodiment, further illustrate the present invention.
Embodiment 1
Fructus Toosendan 9g, Herba Artemisiae Scopariae 30g, Fructus Gardeniae 12g, Radix Salviae Miltiorrhizae 15g, Poria 10g, Rhizoma Alismatis 10g, Radix Pseudostellariae 9g.
Embodiment 2
Fructus Toosendan 12g, Herba Artemisiae Scopariae 30g, Fructus Gardeniae 10g, Radix Salviae Miltiorrhizae 15g, Poria 8g, Rhizoma Alismatis 10g, Radix Pseudostellariae 6g.
Practical example 3
Fructus Toosendan 8g, Herba Artemisiae Scopariae 25g, Fructus Gardeniae 10g, Radix Salviae Miltiorrhizae 12g, Poria 10g, Rhizoma Alismatis 10g, Radix Pseudostellariae 9g.
The present invention implements by following measure: adopt slow fire to decoct with water required raw material of Chinese medicine, and concentrated after filtering, pack in bottle, every bottle of 250ml adds the Mel of 10ml in addition in every bottle, encapsulates standby.
Usage and dosage of the present invention: patient's morning and evening service once every day, each serving 125ml.
Although above the specific embodiment of the present invention has been given to describe in detail and explanation; but what should indicate is; we can carry out various equivalences to above-mentioned embodiment according to conception of the present invention and change and revise; when its function producing does not exceed spiritual that description contains yet, all should be within protection scope of the present invention.
Claims (3)
1. treat a Chinese medicine preparation for hepatitis B, it is characterized in that being made by the raw material of Chinese medicine of following weight: Fructus Toosendan 4-15g, Herba Artemisiae Scopariae 20-40g, Fructus Gardeniae 8-18g, Radix Salviae Miltiorrhizae 10-20g, Poria 6-14g, Rhizoma Alismatis 6-14g, Radix Pseudostellariae 4-15g.
2. a kind of Chinese medicine preparation for the treatment of hepatitis B according to claim 1, is characterized in that being made by the raw material of Chinese medicine of following weight: Fructus Toosendan 6-12g, Herba Artemisiae Scopariae 25-35g, Fructus Gardeniae 10-14g, Radix Salviae Miltiorrhizae 12-18g, Poria 8-12g, Rhizoma Alismatis 8-12g, Radix Pseudostellariae 6-12g.
3. a kind of Chinese medicine preparation for the treatment of hepatitis B according to claim 1, is characterized in that being made by the raw material of Chinese medicine of following weight: Fructus Toosendan 9g, Herba Artemisiae Scopariae 30g, Fructus Gardeniae 12g, Radix Salviae Miltiorrhizae 15g, Poria 10g, Rhizoma Alismatis 10g, Radix Pseudostellariae 9g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310063985.8A CN104013745A (en) | 2013-03-01 | 2013-03-01 | Traditional Chinese medicine preparation for treating hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310063985.8A CN104013745A (en) | 2013-03-01 | 2013-03-01 | Traditional Chinese medicine preparation for treating hepatitis B |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104013745A true CN104013745A (en) | 2014-09-03 |
Family
ID=51430928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310063985.8A Withdrawn CN104013745A (en) | 2013-03-01 | 2013-03-01 | Traditional Chinese medicine preparation for treating hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104013745A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1109339A (en) * | 1994-03-31 | 1995-10-04 | 韩瑞星 | Powder for curing hepatitis B |
| CN1165679A (en) * | 1997-06-04 | 1997-11-26 | 郝中礼 | Classified liver treating agent and it prepn. method |
| CN102366477A (en) * | 2011-10-26 | 2012-03-07 | 张培玉 | Pure traditional Chinese medicine preparation for treating hepatitis |
-
2013
- 2013-03-01 CN CN201310063985.8A patent/CN104013745A/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1109339A (en) * | 1994-03-31 | 1995-10-04 | 韩瑞星 | Powder for curing hepatitis B |
| CN1165679A (en) * | 1997-06-04 | 1997-11-26 | 郝中礼 | Classified liver treating agent and it prepn. method |
| CN102366477A (en) * | 2011-10-26 | 2012-03-07 | 张培玉 | Pure traditional Chinese medicine preparation for treating hepatitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101637585B (en) | Chinese herbal preparation for treating posirasis and preparation method thereof | |
| CN102579912B (en) | Chinese medicinal capsules special for treating acute mastitis and preparation method thereof | |
| CN103110844B (en) | Traditional Chinese medicine for treating acute tonsillitis | |
| CN103977358A (en) | Oral traditional Chinese medicine for lowering lipid and protecting liver | |
| CN102631593B (en) | Preparation method of traditional Chinese medicine lotion for treating oedema lymphangitis | |
| CN104606582A (en) | Traditional Chinese medicine formula for treating anemofrigid-damp arthralgia | |
| CN103977366A (en) | Medicine for treating chronic cholecystitis | |
| CN103520573A (en) | Traditional Chinese medicine for treating liver depression and blood stasis syndrome type breast nodule diseases | |
| CN103142920B (en) | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof | |
| CN102908555B (en) | Traditional Chinese medicine for treating edema | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN103656365A (en) | Traditional Chinese medicine for treating heart and liver yin deficiency syndrome type hyperthyroidism | |
| CN103520571A (en) | Traditional Chinese medicine for treating qi stagnation and blood stasis syndrome type abdominal mass diseases | |
| CN102327524A (en) | Traditional Chinese medicine composition for curing erysipelas | |
| CN101972332A (en) | Traditional Chinese medicine for treating palpitations | |
| CN105125887A (en) | Traditional Chinese medicine for treating tumor and neck, shoulder, waist and leg pain | |
| CN103948763A (en) | Traditional Chinese medicinal composition for treating hepatosis | |
| CN104257813B (en) | A kind of Chinese medicine composition of QI and blood regulating and preparation method thereof | |
| CN104013745A (en) | Traditional Chinese medicine preparation for treating hepatitis B | |
| CN102961527B (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN103495087B (en) | Traditional Chinese medicine for treating erysipelas of lower limbs | |
| CN102861292A (en) | Medicament for treating esophageal cancer and preparation method thereof | |
| CN102488818B (en) | Pharmaceutical composition for treating rheumatism and rheumatoid arthritis | |
| CN102178883B (en) | Preparation method of traditional Chinese medicine for treating hunger type frostbite | |
| CN101961465B (en) | Chinese medicament for treating thrombus of portal system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20140903 |
|
| WW01 | Invention patent application withdrawn after publication |